Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bassline Productions, Inc. (OTC: BSSP).

Full DD Report for BSSP

You must become a subscriber to view this report.


Recent News from (OTC: BSSP)

Cantech Holding, Inc. (BSSP) Announces Execution of Memorandum of Understanding With the TCM Group for the Creation of a Joint Venture and Development of a New Compound for Inclusion in the Doctor at Home Program in Mexico
MONROVIA, CA--(Marketwired - May 10, 2017) - Cantech Holding, Inc., formerly Reve Technologies, Inc., ( OTC PINK : BSSP ) (the "Company" or "Cantech") a development stage immunotherapeutic based technology company today announced it has executed a Memorandum of Understanding (the "MOU") bet...
Source: Marketwired
Date: May, 10 2017 20:33
Cantech Holding, Inc. (BSSP) Announces Formal Negotiations for LOI/Business Collaboration With Zelor S.A.P.I., Mexico
MONROVIA, CA--(Marketwired - Aug 19, 2016) - Cantech Holding, Inc., formerly Reve Technologies, Inc., ( OTC PINK : BSSP ) (the "Company" or "Cantech") a development stage immunotherapeutic based technology company today announced it has received a Letter of Intent which proposes a business ...
Source: Marketwired
Date: August, 19 2016 12:52
Cantech Holding, Inc. Announces Letter to Shareholders
MONROVIA CA / ACCESSWIRE / June 9, 2016 / Cantech Holding, Inc. f/k/a Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Cantech") a development stage immunotherapeutic based technology company today announced a Letter to Shareholders updating current activities and outlining its corpo...
Source: ACCESSWIRE IA
Date: June, 09 2016 11:01
Reve Technologies, Inc. Announces Change Of Name To Cantech Holding, Inc. and Its Domicile to Wyoming from Nevada
MONROVIA CA / ACCESSWIRE / June 6, 2016 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") a development stage immunotherapeutic based technology company today announced that it changed its name to Cantech Holding, Inc. and has moved its domicile to Wyoming from Neveda, effect...
Source: ACCESSWIRE IA
Date: June, 06 2016 08:33
Reve Announces Closing Exclusive License for Cantecks IPF Irreversable Pepsin Fraction Specificto Cancer Indication Only, For Mexico
Moves Ahead On Its Immunotherapeutic IPF Platform Technology for Development, Manufacture and Commercialization MONROVIA, CA / ACCESSWIRE / May 10, 2016 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") a development stage technology company is pleased to announce it ha...
Source: ACCESSWIRE IA
Date: May, 10 2016 08:33
Reve Acquires Exclusive License for Canteck's IPF Irreversable Pepsin Fraction Specific to Cancer Indication Only for Mexico
Embarks on Shift to Immunotherapeutic IPF Platform Technology for Development, Manufacture and Commercialization SAN CLEMENTE CA / ACCESSWIRE / April 25, 2016 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") a development stage technology company is pleased to announce...
Source: ACCESSWIRE IA
Date: April, 25 2016 09:31
Reve Technologies, Inc. Announces 24 Mo. Capital Purchase Plan
To Implement the Capital Purchase Agreement f/k/a CPA; Blueprint for 2016 and 2017 SCOTTSDALE, AZ / ACCESSWIRE / December 22, 2015 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") is pleased to announce the plan of its new Capital Purchase division for the next 24 ...
Source: ACCESSWIRE IA
Date: December, 22 2015 15:50
Reve Technologies, Inc. Appoints William Bozsnyak as a Strategic Advisor to the Board December 3, 2015
To Assist Implementation for the Reve Capital Purchase Division SCOTTSDALE, AZ / ACCESSWIRE / December 3, 2015 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") is pleased to announce it has appointed William Bozsnyak as a strategic advisor to the Board. Mr. Bozsnyak ...
Source: ACCESSWIRE IA
Date: December, 03 2015 14:00
Reve Announces Initiating Set Up For A New Capital Purchase Division to Launch Q1 2016
To Provide Short Term Capital Purchase Assistance across the Diversified Financial Market Sectors SCOTTSDALE, AZ / ACCESSWIRE / December 1, 2015 / Reve Technologies, Inc. (OTCPK: BSSP) (the "Company" or "Reve") is pleased to announce initiation, and set up, for its proposed new Capital...
Source: ACCESSWIRE IA
Date: December, 01 2015 13:20

 


About Bassline Productions, Inc. (OTC: BSSP)

Logo for Bassline Productions, Inc. (OTC: BSSP)

The Company is now in process of seeking a merger or acquisition candidate. Effective October , the PSA Agreement with Cantech Pharma, inc. has been rescinded do inability to proceed with the license for Mexico that previously had focused on its immunotherapeutic based technology specific to Cancer indication. Cantech Holding, Inc., f/k/a Reve Technologies, Inc., f/k/a Bassline Productions, Inc. was formerly involved as an immunotherapeutic based technology company focused on investing in development of, manufacture and commercialization of its then lead product Irreversible Pepsin Fraction IPF specific to the Cancer indication only, exclusively licensed for the United Mexican States.

 

Contact Information

 

 

Current Management

  • Dennis Alexander / CEO
  • Joanne M. Sylvanus / CFO, Secretary
  • Dennis Alexander / Chairman
  • Joanne M. Sylvanus /

Current Share Structure

  • Market Cap: $391,256 - 03/12/2018
  • Issue and Outstanding: 3,912,559,703 - 06/08/2016
  • Float: 3,879,224,233 - 09/26/2014

 


Recent Filings from (OTC: BSSP)

Certification of termination of registration of a class of security under Section 12(g) or notice of suspension of duty to file reports under Section 13 and 15(d) of the Act Section 12 (g).
Filing Type: 15-12GFiling Source: edgar
Filing Date: August, 16 2017
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 16 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 23 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 03 2016
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: May, 10 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2016
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2016
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: January, 27 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 14 2016
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: January, 13 2016

 

 


Daily Technical Chart for (OTC: BSSP)

Daily Technical Chart for (OTC: BSSP)


Stay tuned for daily updates and more on (OTC: BSSP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BSSP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSSP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BSSP and does not buy, sell, or trade any shares of BSSP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/